Displaying drugs 14701 - 14725 of 14958 in total
3-(Prop-2-Ene-1-Sulfinyl)-Propene-1-Thiol
Experimental
Dihydroquinidine barbiturate
Experimental
RG-7795
Investigational
P-Hydroxybenzaldehyde
Experimental
VLTS-589
VLTS-589 consists of plasmid encoding the angiomatrix protein Del-1 in conjunction with poloxamer 188 for the treatment of peripheral vascular disease.
Investigational
Mebicar
Experimental
Lawsone
Experimental
BTA9881
BTA9881 is a respiratory syncytial virus (RSV) antiviral drug developed by the Australian company Biota Holdings. It is currently in phase I trials.
Investigational
Plinabulin
Investigational
Isopentyl Pyrophosphate
Experimental
Pentyl Trihydrogen Diphosphate
Experimental
1,1,1-TRIFLUORO-3-(OCTYLTHIO)ACETONE
Experimental
CHGN111
CHGN111 is an inhibitor of the mitochondrial enzyme CLK-1 which is a demethoxyubiquinone hydroxylase. Numerous parameters of mitochondrial function are altered when the activity of CLK-1 is reduced, which results in a decrease of ROS at critical cellular sites, as well as in a decrease of systemic oxidative stress. It...
Investigational
R1295
R1295 is an integrin antagonist currently in clinical trials for the treatment of rheumatoid arthritis. Integrins are associated to the pathology seen in some of the autoimmune diseases such as rheumatoid arthritis.
Investigational
Flaviolin
Experimental
DPI59
Experimental
Displaying drugs 14701 - 14725 of 14958 in total